J&J's Kenvue IPO targets $40B valuation for consumer health unit.
Johnson & Johnson has announced the launch of Kenvue Inc.'s IPO roadshow, with 151,204,000 shares of common stock to be offered at a price between $20.00 and $23.00 per share. After the IPO, Johnson & Johnson will own 91.9% of Kenvue's common stock. The company has applied to list its common stock on the New York Stock Exchange under the symbol "KVUE". Goldman Sachs, J.P. Morgan, and BofA Securities are acting as joint lead book-running managers for the IPO.
